Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 9/20 | 0.68 |
| ▸ | CYP2A6 | P11509 | 7/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.41 |
| ▸ | NQO1 | P15559 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27996595 | 0.98 | CYP1A2 (0.65) | CYP1A2CYP2A6TDP1ALDH1A1HSD17B10 | |
| Benzoquinone SCHEMBL28278549 | 0.89 | CYP1A2 (0.55) | CYP1A2CYP2A6TDP1ALDH1A1HSD17B10 | |
| SCHEMBL11578182 | 0.84 | CYP1A2 (0.56) | CYP1A2CYP2A6TDP1ALDH1A1HSD17B10 | |
| SCHEMBL599566 | 0.84 | CYP1A2 (0.70) | CYP1A2CYP2A6TDP1ALDH1A1HSD17B10 | |
| SCHEMBL21836746 | 0.83 | CYP1A2 (0.54) | CYP1A2CYP2A6ALDH1A1HSD17B10HPGD | |
| SCHEMBL15413016 | 0.81 | CYP1A2 (0.48) | CYP1A2CYP2A6ALDH1A1HSD17B10HPGD | |
| SCHEMBL598829 | 0.81 | CYP1A2 (1.00) | CYP1A2CYP2A6TDP1ALDH1A1HSD17B10 | |
| SCHEMBL29352143 | 0.81 | CYP1A2 (1.00) | CYP1A2CYP2A6TDP1ALDH1A1HSD17B10 | |
| Propane SCHEMBL28444183 | 0.80 | CYP1A2 (0.87) | CYP1A2CYP2A6TDP1ALDH1A1HSD17B10 | |
| Ammonia Solution, Strong SCHEMBL27919233 | 0.79 | CYP1A2 (0.95) | CYP1A2CYP2A6TDP1ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3971810-A | Solid pesticidal chlorinated phenolic concentrates | PHILLIPS PETROLEUM COMPANY (US) | 1976-07-27 | — | — | US | claimed |
| CN-111855790-A | Method for identifying specific aromatic compounds in complex environment sample | 中国科学院生态环境研究中心 | 2020-10-30 | — | — | CN | disclosed |
| US-20120202766-A1 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET, INC. (US) | 2012-08-09 | — | — | US | disclosed |
| US-8114997-B2 | N4-acylcytosine nucleosides for treatment of viral infections | PHARMASSET, INC. (US) | 2012-02-14 | — | — | US | disclosed |
| US-RE42015-E1 | N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections | PHARMASSET, INC. (US) | 2010-12-28 | — | — | US | disclosed |
| US-20100236936-A1 | Aqueous,alkaline,cyanide-free bath for the galvanic deposition of zinc and zinc alloy coatings | ATOTECH DEUTSCHLAND GMBH (DE) | 2010-09-23 | — | — | US | disclosed |
| US-20100155257-A1 | Aqueous, alkaline, cyanide-free bath for the galvanic deposition of zinc alloy coatings | ATOTECH DEUTSCHLAND GMBH (DE) | 2010-06-24 | — | — | US | disclosed |
| US-20090176730-A1 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET, INC. (US) | 2009-07-09 | — | — | US | disclosed |
| EP-1569652-A4 | N SP 4 /SP-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS | PHARMASSET INC (US) | 2008-07-02 | — | — | EP | disclosed |
| US-20070078080-A1 | N4-Acylcytosine Nucleosides for Treatment of Viral Infections | GILEAD PHARMASSET LLC | 2007-04-05 | — | — | US | disclosed |
| US-5858571-A | TREATING A PULVERIZED HYDROGEN ABSORBING ALLOY WITH A SOLUTION COMPRISING A CONJUGATED UNSATURATED COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| EP-0872903-A1 | Method for making hydrogen storage alloy powder and electrode comprising the alloy powder | Shin-Etsu Chemical Co., Ltd. (JP) | 1998-10-21 | — | — | EP | disclosed |
| US-5171880-A | Sulfur or oxidized sulfur in a base | ALLIED-SIGNAL INC. (US) | 1992-12-15 | — | — | US | disclosed |
| US-5171891-A | Using sulfur containing oxy acids and their salts | ALLIED-SIGNAL INC. (US) | 1992-12-15 | — | — | US | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4131646-A | Preparation of hydrogen peroxide from dihydroanthracene hydroperoxides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1978-12-26 | — | — | US | disclosed |
| US-3971810-A | Solid pesticidal chlorinated phenolic concentrates | PHILLIPS PETROLEUM COMPANY (US) | 1976-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070078080-A1 | N4-Acylcytosine Nucleosides for Treatment of Viral Infections | ENTPD5, DUT, NT5C3B | CYP1A2 1240/4885CYP2A6 1327/4885TDP1 1800/4885 |
| US-20090176730-A1 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | ENTPD5, NT5C3B, PNP | CYP1A2 1415/4885CYP2A6 1388/4885TDP1 1753/4885 |
| US-20120202766-A1 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | ENTPD5, DUT, NT5C3B | CYP1A2 1174/4885CYP2A6 1296/4885TDP1 1794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.